Oct 26, 2016· Comment from National Consumers League (NCL)· FDA-2015-N-3326-0025
Filed on regulations.gov — full text not in the inline record.
FDANonrulemakingFDA-2015-N-3326
Biosimilar User Fee Act
RIN
—
Last modified
Jan 2, 2026
Comment window
closed 207d ago
National Consumers League filings
1
Activity
National Consumers League filed 1 comment on this docket between Oct 26, 2016 and Oct 26, 2016. 13 other organizations filed here. The comment window closed 207d ago.
What National Consumers League filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (13)
See everyone who commented →- National Consumers LeagueTHIS ORG1 filing · confidence 85%
- Association for Accessible Medicinestrade assoc.3 filings · confidence 97%
- Arthritis Foundationtrade assoc.2 filings · confidence 85%
- American Federation of Statetrade assoc.1 filing · confidence 85%
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- Biologics Coalitiontrade assoc.1 filing · confidence 85%
- CELLTRION Inc.unverified attribution1 filing · confidence 70%
- Generic Pharmaceutical Association (GPhA) and Biosimilar Counciltrade assoc.1 filing · confidence 85%
- Generic Pharmaceutical Association (GPhA) and Biosimilars Counciltrade assoc.1 filing · confidence 85%
- Healthcare Supply Chain Associationtrade assoc.1 filing · confidence 85%
- Hepatitis Foundation Internationaltrade assoc.1 filing · confidence 85%
- Pfenex Incunverified attribution1 filing · confidence 70%
- Pfizer Inc.unverified attribution1 filing · confidence 70%
- The Alliance for Safe Biologic Medicinestrade assoc.1 filing · confidence 85%